Anika Therapeutics | ANIK - Current Assets

Stock Price
15.40
Daily Change
0.10 0.65%
Monthly
7.24%
Yearly
14.33%
Q2 Forecast
14.36

Anika Therapeutics reported $103.36M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Agenus USD 133.44M 514K Dec/2025
Agios Pharmaceuticals USD 942.05M 91.06M Dec/2025
Anika Therapeutics USD 103.36M 1.77M Dec/2025
Arrowhead Research USD 1.17B 223.75M Dec/2025
Enanta Pharmaceuticals USD 198.68M 5.65M Dec/2025
Halozyme Therapeutics USD 825.21M 503.54M Dec/2025
Heron Therapeutics USD 238.07M 8.67M Dec/2025
Insmed USD 1.79B 137.6M Dec/2025
Integra LifeSciences USD 1.16B 15.96M Dec/2025
Intrexon USD 23.72M 45.04M Jun/2024
J&J USD 55.62B 1.01B Dec/2025
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
Ligand Pharmaceuticals USD 832.27M 78.35M Dec/2025
MacroGenics USD 219.94M 12.15M Dec/2025
Merit Medical Systems USD 1.04B 54.62M Dec/2025
Rigel Pharmaceuticals USD 214.93M 39.53M Sep/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Smith & Nephew USD 4.63B 169M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Surmodics USD 75.99M 5.31M Jun/2025
Veracyte USD 488.38M 39.15M Dec/2025
Xencor USD 599.82M 81.38M Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025